Cancer has claimed many lives for years. Being among the leading medical problem in the world, scientists and researchers have massively invested in finding treatment solutions for the disease. Currently, scientific research offers many platforms for treatment through policies and effective drug use. In the past, cancer was a mystery to medical practitioners and families. With the onset of technology, researchers have been able to conduct progressive treatments and therapies. One way in which scientists have invested in finding treatment options is through Oncotarget. The peer-reviewed journal offers a clear understanding of diseases and treatment. The chief editor of the journal is a qualified scientist with expertise. Mikhail Blagosklonny provides insight on cancer and the newly available treatments through Oncotarget. Oncotarget is a scientific journal created for sharing and distributing information about cancer treatment as well as other diseases universally.
The global initiative towards a world free of diseases is continuously gaining momentum. Towards this end, organizations and governments have adopted modern research-based platforms for treatment. Oncotarget is one of the best platforms for bridging the gap between the current knowledge on medical issues and the new insights on the same problems, treatment. The journal has largely contributed to treatment through the weekly-published articles. The publishing of found researches through Oncotarget has massively aided in the fight against cancer as well as other diseases.
Oncotarget additionally capitalizes on the effects of management programs as well as modern therapeutic agents on patients through the quality of life. This journal emphasizes on the importance of drug adherence to patients. It explores the proof behind current and existing therapies about the improvement of outcomes. Oncotarget seeks to define the usage of medication and treatments concerning eventual uptake as well as acceptance by the health care providers to patients. Recently, the journal featured an article on the effects of e-cigarettes on health. Unlike the common misconception that e-cigarettes have no health hazards, Oncotarget highlighted that e-cigarettes have adverse effects on the gum. Oncotarget is published by Impact Journals
Additionally, the journal indicated that there is a new subtype of cancer. The open source peer-reviewed journal plays a critical role in distributing information on cancer treatments, therapies as well as other diseases. With Oncotarget in the medical field, the society is headed to a disease free world. Oncotarget is also available on Dove Press.